<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>FC AECC - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/fc-aecc/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/fc-aecc/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Sat, 22 Sep 2018 10:43:22 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>FC AECC - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/fc-aecc/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>GB, Italia e Spagna alleate contro cancro, 33mln per ricerca</title>
		<link>https://www.newpharmaitaly.it/gb-italia-e-spagna-alleate-contro-cancro-33mln-per-ricerca/</link>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Sat, 22 Sep 2018 10:43:22 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Accelerator Award]]></category>
		<category><![CDATA[AIRC]]></category>
		<category><![CDATA[Cancer Research UK]]></category>
		<category><![CDATA[Car-T]]></category>
		<category><![CDATA[FC AECC]]></category>
		<category><![CDATA[Federico Caligaris Cappio]]></category>
		<category><![CDATA[GB]]></category>
		<category><![CDATA[immunoterapia]]></category>
		<category><![CDATA[Italia]]></category>
		<category><![CDATA[Spagna]]></category>
		<guid isPermaLink="false">http://www.newpharmaitaly.it/?p=3137</guid>

					<description><![CDATA[<p>Con 6 nuovi programmi, da immunoterapia a tecnica CAR-T Regno Unito, Italia e Spagna alleate contro il cancro, con un investimento di oltre 33 milioni di euro e 6 nuovi programmi di ricerca per accelerare lo sviluppo di risorse per l&#8217;oncologia. Sono gli studi quinquennali dell&#8217;Accelerator Award, un programma internazionale per imprimere un&#8217;accelerazione a ricerche [&#8230;]</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/gb-italia-e-spagna-alleate-contro-cancro-33mln-per-ricerca/">GB, Italia e Spagna alleate contro cancro, 33mln per ricerca</a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
